These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 35857172

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ultralow-dose [18F]FDG PET/CT imaging: demonstration of feasibility in dynamic and static images.
    Tan H, Qi C, Cao Y, Cai D, Mao W, Yu H, Sui X, Liu G, Shi H.
    Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18 F-fluorodeoxyglucose-positron emission tomography and CT perfusion study.
    Yang DM, Palma D, Louie A, Malthaner R, Fortin D, Rodrigues G, Yaremko B, Laba J, Gaede S, Warner A, Inculet R, Lee TY.
    J Med Imaging Radiat Oncol; 2019 Feb; 63(1):94-101. PubMed ID: 30281918
    [Abstract] [Full Text] [Related]

  • 6. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
    Tan H, Sui X, Yin H, Yu H, Gu Y, Chen S, Hu P, Mao W, Shi H.
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma.
    Zhou LM, Yuan LL, Gao Y, Liu XS, Dai Q, Yang JW, Pei ZJ.
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):904-912. PubMed ID: 32856112
    [Abstract] [Full Text] [Related]

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Mar; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 11. Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT.
    Zhao YM, Li YH, Chen T, Zhang WG, Wang LH, Feng J, Li C, Zhang X, Fan W, Hu YY.
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of dynamic 18F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes.
    Sun Y, Xiao L, Wang Y, Liu C, Cao L, Zhai W, Wang B, Yu S, Xin J.
    Quant Imaging Med Surg; 2023 Apr 01; 13(4):2556-2567. PubMed ID: 37064404
    [Abstract] [Full Text] [Related]

  • 13. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients.
    Sari H, Mingels C, Alberts I, Hu J, Buesser D, Shah V, Schepers R, Caluori P, Panin V, Conti M, Afshar-Oromieh A, Shi K, Eriksson L, Rominger A, Cumming P.
    Eur J Nucl Med Mol Imaging; 2022 May 01; 49(6):1997-2009. PubMed ID: 34981164
    [Abstract] [Full Text] [Related]

  • 14. Short dynamic FDG-PET imaging protocol for patients with lung cancer.
    Torizuka T, Nobezawa S, Momiki S, Kasamatsu N, Kanno T, Yoshikawa E, Futatsubashi M, Okada H, Ouchi Y.
    Eur J Nucl Med; 2000 Oct 01; 27(10):1538-42. PubMed ID: 11083544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.
    Invest Radiol; 2013 May 01; 48(5):247-55. PubMed ID: 23519008
    [Abstract] [Full Text] [Related]

  • 18. Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma.
    Fu L, Alam MS, Ren Y, Guan W, Wu H, Wang Q, Han Y, Zhou W, Li H, Wang Z.
    Clin Lung Cancer; 2018 May 01; 19(3):221-229. PubMed ID: 29275041
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.